Tracon Pharmaceuticals, Inc. (TCON) has 142 open-market insider trades by 29 insiders since 2015. The most active filer is Charles Theuer, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Ravi Viswanathan | 10% Owner | — | 3 | $18.8M | 2018-03-27 |
| Scott D. Sandell | 10% Owner | — | 3 | $18.8M | 2018-03-27 |
| Forest Baskett | 10% Owner | — | 3 | $18.8M | 2018-03-27 |
| David M. Mott | 10% Owner | — | 2 | $15.0M | 2016-11-29 |
| Peter W. Sonsini | 10% Owner | — | 2 | $15.0M | 2016-11-29 |
| Anthony A. Florence Jr. | 10% Owner | — | 2 | $15.0M | 2016-11-29 |
| M. James Barrett | 10% Owner | — | 2 | $15.0M | 2016-11-29 |
| Krishna Kittu Kolluri | 10% Owner | — | 2 | $15.0M | 2016-11-29 |
| Patrick J. Kerins | 10% Owner | — | 2 | $15.0M | 2016-11-29 |
| Opaleye Management Inc. | 10% Owner | — | 35 | $14.1M | 2023-11-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner | Sell | $2.8M | 2023-11-10 |
| Charles Theuer | President | Buy | $38K | 2023-04-26 |
| Opaleye Management Inc. | 10% Owner | Buy | $482K | 2023-03-09 |
| Charles Theuer | President | Buy | $8K | 2023-02-28 |
| Charles Theuer | President | Buy | $11K | 2023-01-18 |
| Scott B. Brown | CFO | Buy | $5K | 2022-12-29 |
Companies that share insiders with TCON, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| William R. Larue | Director | Sell | $151 | 2022-12-21 |
| Charles Theuer | President | Buy | $30K | 2022-12-14 |
| Opaleye Management Inc. | 10% Owner | Buy | $211K | 2022-12-14 |
| Opaleye Management Inc. | 10% | Sell | $2K | 2022-12-06 |
| Charles Theuer | President | Buy | $20K | 2022-11-18 |
| Charles Theuer | President | Buy | $14K | 2022-11-03 |
| Charles Theuer | President | Buy | $10K | 2022-11-02 |
| Opaleye Management Inc. | 10% | Buy | $21K | 2022-10-18 |
| Charles Theuer | President | Buy | $9K | 2022-10-07 |